To investigate whether elevated levels of PRMT5 regulate WNT/β‐CATENIN proliferative signalling in breast cancer, we checked expression of all three WNT/β‐CATENIN pathway target genes in MCF7, HCC1937 and BT549 cell lines. The gene discussed is PRMT5; the disease is breast carcinoma.